J004-1227 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole

J004-1227 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole
J004-1227 Screening compound: 3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound J004-1227
3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J004-1227

Molecular Formula

C15H15FN2O2 (C15 H15 FN2 O2)

Compound Name

3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole

IUPAC name

3-[1-(2-fluorobenzoyl)pyrrolidin-2-yl]-5-methyl-12-oxazole

SMILES

Cc1cc(C(CCC2)N2C(c(cccc2)c2F)=O)no1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

274.29

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.551

Distribution Coefficient, logD

2.551

Water Solubility, LogSw

-2.86

Polar Surface Area

37.903

Acid Dissociation Constant (pKa)

26.74

Base Dissociation Constant (pKb)

-3.95

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

J004-1227 in Drug Discovery

Included in Screening Libraries

Fragments Library (11262 compounds)

GABA Library (7115 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Structure:
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Cancer
Targets:
  • GPCR
  • Ion Channels
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators

References: we are preparing a list of scientific research reports with J004-1227 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J004-1227?
Check Price and Availability of J004-1227, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J004-1227 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J004-1227
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J004-1227
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J004-1227 available by request